Local Control Modality and Outcome for Ewing Sarcoma of the Femur

A Report From the Children’s Oncology Group

Najat C. Daw, Nadia N Laack, Elizabeth J. McIlvaine, Mark Krailo, Richard B. Womer, Linda Granowetter, Holcombe E. Grier, Neyssa M. Marina, Mark L. Bernstein, Mark C. Gebhardt, Karen J. Marcus, Shailesh M. Advani, John H. Healey, George D. Letson, Richard G. Gorlick, R. Lor Randall

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The choice of a local control (LC) modality for Ewing sarcoma (EWS) of the femur is controversial. This study aimed to determine the effect of LC modality on tumor LC and patient outcomes. Methods: The study reviewed the treatment and outcomes for 115 patients who had EWS of the femur treated with similar chemotherapy in three cooperative group trials. Patient outcomes were analyzed according to the LC modality using the log-rank test and the cumulative incidence of local or distant failure using competing risks regression. Results: The median age of the patients was 13 years. The most common tumor location was the proximal femur followed by the mid femur. For 55 patients with available data, the tumor was larger than 8 cm in 29 patients and 8 cm or smaller in 26 patients. For 84 patients (73 %), surgery only was performed, whereas 17 patients (15 %) had surgery plus radiation, and 14 patients (12 %) had radiation only. The 5-year event-free survival (EFS) rate was 65 % (95 % confidence interval [CI], 55–73 %), and the 5-year overall survival (OS) rate was 70 % (95 % CI, 61–78 %). Patient outcomes did not differ significantly according to tumor location within the femur (proximal, mid or distal) or tumor size (

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalAnnals of Surgical Oncology
DOIs
StateAccepted/In press - May 23 2016

Fingerprint

Ewing's Sarcoma
Femur
Neoplasms
Survival Rate
Confidence Intervals
Radiation
Disease-Free Survival

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Local Control Modality and Outcome for Ewing Sarcoma of the Femur : A Report From the Children’s Oncology Group. / Daw, Najat C.; Laack, Nadia N; McIlvaine, Elizabeth J.; Krailo, Mark; Womer, Richard B.; Granowetter, Linda; Grier, Holcombe E.; Marina, Neyssa M.; Bernstein, Mark L.; Gebhardt, Mark C.; Marcus, Karen J.; Advani, Shailesh M.; Healey, John H.; Letson, George D.; Gorlick, Richard G.; Lor Randall, R.

In: Annals of Surgical Oncology, 23.05.2016, p. 1-7.

Research output: Contribution to journalArticle

Daw, NC, Laack, NN, McIlvaine, EJ, Krailo, M, Womer, RB, Granowetter, L, Grier, HE, Marina, NM, Bernstein, ML, Gebhardt, MC, Marcus, KJ, Advani, SM, Healey, JH, Letson, GD, Gorlick, RG & Lor Randall, R 2016, 'Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group', Annals of Surgical Oncology, pp. 1-7. https://doi.org/10.1245/s10434-016-5269-1
Daw, Najat C. ; Laack, Nadia N ; McIlvaine, Elizabeth J. ; Krailo, Mark ; Womer, Richard B. ; Granowetter, Linda ; Grier, Holcombe E. ; Marina, Neyssa M. ; Bernstein, Mark L. ; Gebhardt, Mark C. ; Marcus, Karen J. ; Advani, Shailesh M. ; Healey, John H. ; Letson, George D. ; Gorlick, Richard G. ; Lor Randall, R. / Local Control Modality and Outcome for Ewing Sarcoma of the Femur : A Report From the Children’s Oncology Group. In: Annals of Surgical Oncology. 2016 ; pp. 1-7.
@article{60302af937264cc7b6490a1bb94dc60f,
title = "Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group",
abstract = "Background: The choice of a local control (LC) modality for Ewing sarcoma (EWS) of the femur is controversial. This study aimed to determine the effect of LC modality on tumor LC and patient outcomes. Methods: The study reviewed the treatment and outcomes for 115 patients who had EWS of the femur treated with similar chemotherapy in three cooperative group trials. Patient outcomes were analyzed according to the LC modality using the log-rank test and the cumulative incidence of local or distant failure using competing risks regression. Results: The median age of the patients was 13 years. The most common tumor location was the proximal femur followed by the mid femur. For 55 patients with available data, the tumor was larger than 8 cm in 29 patients and 8 cm or smaller in 26 patients. For 84 patients (73 {\%}), surgery only was performed, whereas 17 patients (15 {\%}) had surgery plus radiation, and 14 patients (12 {\%}) had radiation only. The 5-year event-free survival (EFS) rate was 65 {\%} (95 {\%} confidence interval [CI], 55–73 {\%}), and the 5-year overall survival (OS) rate was 70 {\%} (95 {\%} CI, 61–78 {\%}). Patient outcomes did not differ significantly according to tumor location within the femur (proximal, mid or distal) or tumor size (",
author = "Daw, {Najat C.} and Laack, {Nadia N} and McIlvaine, {Elizabeth J.} and Mark Krailo and Womer, {Richard B.} and Linda Granowetter and Grier, {Holcombe E.} and Marina, {Neyssa M.} and Bernstein, {Mark L.} and Gebhardt, {Mark C.} and Marcus, {Karen J.} and Advani, {Shailesh M.} and Healey, {John H.} and Letson, {George D.} and Gorlick, {Richard G.} and {Lor Randall}, R.",
year = "2016",
month = "5",
day = "23",
doi = "10.1245/s10434-016-5269-1",
language = "English (US)",
pages = "1--7",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",

}

TY - JOUR

T1 - Local Control Modality and Outcome for Ewing Sarcoma of the Femur

T2 - A Report From the Children’s Oncology Group

AU - Daw, Najat C.

AU - Laack, Nadia N

AU - McIlvaine, Elizabeth J.

AU - Krailo, Mark

AU - Womer, Richard B.

AU - Granowetter, Linda

AU - Grier, Holcombe E.

AU - Marina, Neyssa M.

AU - Bernstein, Mark L.

AU - Gebhardt, Mark C.

AU - Marcus, Karen J.

AU - Advani, Shailesh M.

AU - Healey, John H.

AU - Letson, George D.

AU - Gorlick, Richard G.

AU - Lor Randall, R.

PY - 2016/5/23

Y1 - 2016/5/23

N2 - Background: The choice of a local control (LC) modality for Ewing sarcoma (EWS) of the femur is controversial. This study aimed to determine the effect of LC modality on tumor LC and patient outcomes. Methods: The study reviewed the treatment and outcomes for 115 patients who had EWS of the femur treated with similar chemotherapy in three cooperative group trials. Patient outcomes were analyzed according to the LC modality using the log-rank test and the cumulative incidence of local or distant failure using competing risks regression. Results: The median age of the patients was 13 years. The most common tumor location was the proximal femur followed by the mid femur. For 55 patients with available data, the tumor was larger than 8 cm in 29 patients and 8 cm or smaller in 26 patients. For 84 patients (73 %), surgery only was performed, whereas 17 patients (15 %) had surgery plus radiation, and 14 patients (12 %) had radiation only. The 5-year event-free survival (EFS) rate was 65 % (95 % confidence interval [CI], 55–73 %), and the 5-year overall survival (OS) rate was 70 % (95 % CI, 61–78 %). Patient outcomes did not differ significantly according to tumor location within the femur (proximal, mid or distal) or tumor size (

AB - Background: The choice of a local control (LC) modality for Ewing sarcoma (EWS) of the femur is controversial. This study aimed to determine the effect of LC modality on tumor LC and patient outcomes. Methods: The study reviewed the treatment and outcomes for 115 patients who had EWS of the femur treated with similar chemotherapy in three cooperative group trials. Patient outcomes were analyzed according to the LC modality using the log-rank test and the cumulative incidence of local or distant failure using competing risks regression. Results: The median age of the patients was 13 years. The most common tumor location was the proximal femur followed by the mid femur. For 55 patients with available data, the tumor was larger than 8 cm in 29 patients and 8 cm or smaller in 26 patients. For 84 patients (73 %), surgery only was performed, whereas 17 patients (15 %) had surgery plus radiation, and 14 patients (12 %) had radiation only. The 5-year event-free survival (EFS) rate was 65 % (95 % confidence interval [CI], 55–73 %), and the 5-year overall survival (OS) rate was 70 % (95 % CI, 61–78 %). Patient outcomes did not differ significantly according to tumor location within the femur (proximal, mid or distal) or tumor size (

UR - http://www.scopus.com/inward/record.url?scp=84969801932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969801932&partnerID=8YFLogxK

U2 - 10.1245/s10434-016-5269-1

DO - 10.1245/s10434-016-5269-1

M3 - Article

SP - 1

EP - 7

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -